Search - tctmd.com

Displaying 21 - 40 of 1391

Sort: Relevancy | Date

Presentation TCT India 2025

Leaving the right agent Behind

Presenter: Jabir Abdullakutty

July 25, 2025

Presentation Controversies and Advances 2025

MINOCA, ANOCA and INOCA: What’s in a Name!

Presenter: John Beltrame

January 31, 2025

Presentation Miami Valves 2025

Short term ACS post TAVR

Presenter: Pedro E Ureña

January 30, 2025

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Presentation ESC 2024

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Presenter: Derek Chew

September 02, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation ESC 2024

The EARTH-STEMI IPD meta-analysis

Presenter: Gianluca Campo

September 01, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

Presentation EuroPCR 2024

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

Presenter: Mohamed El Farissi

May 14, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation ACC 2024

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Presenter: Javed Butler

April 06, 2024

Presentation THT Abstracts 2024

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Presenter: Rebecca Smoller

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Advertisement

Leaving the right agent Behind

MINOCA, ANOCA and INOCA: What’s in a Name!

Short term ACS post TAVR

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

The EARTH-STEMI IPD meta-analysis

First report of an IDE pivotal study of a dedicated splitting device during TAVR

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content